Data / Form D filings / RHYTHM PHARMACEUTICALS, INC.
RHYTHM PHARMACEUTICALS, INC.: Form D filings
RHYTHM PHARMACEUTICALS, INC., a pharmaceuticals company in Boston, MA, filed 3 Form D notices with the SEC between 2015 and 2017. The latest, on January 20, 2017, reports $20.5 million sold of a $40.9 million offering to 14 investors.
Find out what RHYTHM PHARMACEUTICALS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 500 BOYLSTON STREET, 11TH FLOOR, Boston, MA, 02116
- Phone
- (857) 264-4280
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1649904
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 20, 2017 | New notice | $40,949,999 | $20,475,001 | $20,474,998 | 14 | Jan 6, 2017 | sec.gov |
| Dec 10, 2015 | Amendment | $40,000,000 | $40,000,000 | $0 | 12 | Aug 3, 2015 | sec.gov |
| Aug 12, 2015 | New notice | $40,000,000 | $25,000,000 | $15,000,000 | 12 | Aug 3, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David P. Meeker, M.D. | Director | |
| Neil Exter | Director | |
| David J. McGirr | Director | |
| Jonathan T. Silverstein | Director | |
| Edward T. Mathers | Director | |
| Christophe Jean | Director | |
| Bart T. Henderson | Executive Officer, Promoter | |
| Todd T. Foley | Director | |
| Keith Gottesdiener | Executive Officer, Director, Promoter |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jan 16, 2017 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what RHYTHM PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.